Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-21

Clinical Trial Update: DIalysis Symptom COntrol-Restless Legs Syndrome Trial [Phase 3]

View source ↗

Summary

Phase 3 trial update for a dialysis-related symptom control program targeting Restless Legs Syndrome in patients with End Stage Renal Disease; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Population Health Research Institute | Conditions: End Stage Renal Disease, Restless Legs Syndrome | Phase 3 | Status: COMPLETED